{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:07:07Z","timestamp":1791446827415,"version":"4.3.3"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jacc.2017.12.060","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T14:06:49Z","timestamp":1520258809000},"page":"1063-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["Digoxin and Mortality in Patients With\u00a0Atrial Fibrillation"],"prefix":"10.1016","volume":"71","author":[{"given":"Renato D.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rordorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano M.","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Wojdyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ridefelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Vinereanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Flaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana M.","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Hohnloser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wallentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.12.060_bib1","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.jacc.2014.03.021","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.12.060_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.12.060_bib4","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2015.04.045","article-title":"Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort","volume":"65","author":"Allen","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib5","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/S0140-6736(14)61836-5","article-title":"Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of ROCKET AF","volume":"385","author":"Washam","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2017.12.060_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/hrt.2006.108399","article-title":"Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data","volume":"94","author":"Gjesdal","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2017.12.060_bib7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehs348","article-title":"Increased mortality among patients taking digoxin\u2014analysis from the AFFIRM study","volume":"34","author":"Whitbeck","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.12.060_bib8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00228-007-0346-9","article-title":"Digoxin and mortality in atrial fibrillation: a prospective cohort study","volume":"63","author":"Hallberg","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2017.12.060_bib9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2014.03.060","article-title":"Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study","volume":"64","author":"Turakhia","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/CIRCULATIONAHA.114.013709","article-title":"Rate-control treatment and mortality in atrial fibrillation","volume":"132","author":"Chao","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.12.060_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCEP.114.002292","article-title":"Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study","volume":"8","author":"Freeman","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2014.11.112","article-title":"Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation","volume":"180","author":"Pastori","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: a systematic review and meta-analysis of the literature","volume":"36","author":"Vamos","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.12.060_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.amjcard.2014.05.013","article-title":"Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients\u00a0\u226565 years of age with versus without heart failure","volume":"114","author":"Shah","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib15","article-title":"Digoxin use and subsequent clinical outcomes in patients with atrial fibrillation with or without heart failure in the ENGAGE AF-TIMI 48 Trial","volume":"6","author":"Eisen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2017.12.060_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004573","article-title":"Effect of digoxin use among Medicaid enrollees with atrial fibrillation","volume":"10","author":"Adedinsewo","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/hrt.2009.175786","article-title":"Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation","volume":"96","author":"Friberg","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2017.12.060_bib18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/eurheartj\/eht120","article-title":"Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial","volume":"34","author":"Gheorghiade","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.12.060_bib19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.hrthm.2014.06.007","article-title":"Digoxin in patients with permanent atrial fibrillation: data from the RACE II study","volume":"11","author":"Mulder","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.12.060_bib20","first-page":"483","article-title":"Is there a role for digoxin in atrial fibrillation without heart failure?","volume":"16","author":"Master","year":"2009","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacc.2017.12.060_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5603\/CJ.a2016.0016","article-title":"Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation","volume":"23","author":"Qureshi","year":"2016","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacc.2017.12.060_bib22","doi-asserted-by":"crossref","first-page":"e2409","DOI":"10.1097\/MD.0000000000002409","article-title":"Increased all-cause mortality associated with digoxin therapy in patients with atrial fibrillation: an updated meta-analysis","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2017.12.060_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/FJC.0000000000000274","article-title":"Digoxin is associated with increased all-cause mortality in patients with atrial fibrillation regardless of concomitant heart failure: a meta-analysis","volume":"66","author":"Wang","year":"2015","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2017.12.060_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2015.04.031","article-title":"Digoxin in patients with atrial fibrillation and heart failure: a meta-analysis","volume":"188","author":"Bavishi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2015.01.013","article-title":"Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation","volume":"115","author":"Ouyang","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib26","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: a systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2017.12.060_bib27","first-page":"2095","article-title":"Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure","volume":"38","author":"Bavendiek","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.12.060_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tcm.2016.03.011","article-title":"Digoxin: the good and the bad","volume":"26","author":"Ziff","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2017.12.060_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.12.060_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.12.060_bib31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2017.12.060_bib32","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","article-title":"Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from ARISTOTLE","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.12.060_bib33","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jacc.2012.11.082","article-title":"N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from ARISTOTLE","volume":"61","author":"Hijazi","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jacc.2013.07.093","article-title":"High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin","volume":"63","author":"Hijazi","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.12.060_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.113.006286","article-title":"High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from ARISTOTLE","volume":"129","author":"Hijazi","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.12.060_bib36","doi-asserted-by":"crossref","unstructured":"Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity score weighting. J Am Stat Assoc 2017. In press.","DOI":"10.1080\/01621459.2016.1260466"},{"key":"10.1016\/j.jacc.2017.12.060_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"Van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jacc.2017.12.060_bib38","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1198\/016214501753208573","article-title":"Balanced risk set matching","volume":"96","author":"Li","year":"2001","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.jacc.2017.12.060_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1541-0420.2005.00356.x","article-title":"Propensity score matching with time-dependent covariates","volume":"61","author":"Bo","year":"2005","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2017.12.060_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamainternmed.2013.10432","article-title":"Digitalis use in contemporary clinical practice: refitting the foxglove","volume":"174","author":"Goldberger","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2017.12.060_bib41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ejhf.584","article-title":"Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial","volume":"18","author":"Adams","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2017.12.060_bib42","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCEP.114.002046","article-title":"Interaction between digoxin and dronedarone in the PALLAS trial","volume":"7","author":"Hohnloser","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718301037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109718301037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T03:00:46Z","timestamp":1570849246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109718301037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0735109718301037"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.12.060","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digoxin and Mortality in Patients With\u00a0Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.12.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}